Omrix Reviews

Recommend to a friend
Approve of CEO
(no image)
Robert Taub
1 Rating
  • Part of a global company, but does not feel that way

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - QA Specialist in Ramat Gan (Israel)
    Former Employee - QA Specialist in Ramat Gan (Israel)
    Doesn't Recommend
    Negative Outlook
    Approves of CEO

    I worked at Omrix full-time (More than 3 years)


    Part of Johnson and Johnson. Exposure to some of the global policies and employees, and access to many data sources.


    Does not feel like an actual part of the global company. Very little opportunity for growth, unless you are very well connected to specific managers. Sometimes feels like some of the lower and higher management is threatened by talented people.

    Advice to Management

    Try and keep talented employees, rather than promoting your inner circle

Omrix Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Somerville, NJ
Size 201 to 500 Employees
Founded 1995
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue Unknown / Non-Applicable per year

Omrix Biopharmaceuticals helps keep blood in its place in the operating room. The company develops biosealants derived from human plasma to control bleeding during surgical procedures. The biosealants contain naturally occurring proteins that clot and adhere to tissue. Johnson & Johnson's Ethicon subsidiary markets and distributes these products under the names Evicel in the US and Quixil in Europe. Omrix's Evithrom thrombin product was developed with Ethicon primarily for neurosurgery. The FDA has approved both for hemostasis (minimizing blood loss) during ... More

Work at Omrix? Share Your Experiences


Click to Rate